메뉴 건너뛰기
American Journal of Gastroenterology
Volumn 101, Issue 6, 2006, Pages 1268-1273
A study of low dose peginterferon alpha-2b with ribavirin for the initial treatment of chronic hepatitis C
Author keywords

[No Author keywords available]
Indexed keywords

PEGINTERFERON ALPHA2A; RIBAVIRIN;
EID: 33744796300     PISSN: 00029270     EISSN: 15720241     Source Type: Journal    
DOI: 10.1111/j.1572-0241.2006.00614.x     Document Type: Article
Times cited : (10)
References (17)
  • 1
    • 0037387851 scopus 로고    scopus 로고
    • Projecting future complications of chronic hepatitis C in the United States
    • Davis GL Albright JE Cook SF, et al. Projecting future complications of chronic hepatitis C in the United States. Liver Transpl 2003 9 : 331 8.
    • (2003) Liver Transpl , vol.9 , pp. 331-8
    • Davis, G.L.1    Albright, J.E.2    Cook, S.F.3
  • 2
    • 0035934568 scopus 로고    scopus 로고
    • Peginterferon alfa-2b plus ribavirin compared with interferon alfa-2b plus ribavirin for initial treatment of chronic hepatitis C: A randomized trial
    • Manns MP Hutchison JG Gordon SC, et al. Peginterferon alfa-2b plus ribavirin compared with interferon alfa-2b plus ribavirin for initial treatment of chronic hepatitis C: A randomized trial. Lancet 2001 358 : 958 65.
    • (2001) Lancet , vol.358 , pp. 958-65
    • Manns, M.P.1    Hutchison, J.G.2    Gordon, S.C.3
  • 3
    • 0037179698 scopus 로고    scopus 로고
    • Peginterferon alfa-2a plus ribavirin for chronic hepatitis C virus infection
    • Fried MW Shiffman ML Reddy KR, et al. Peginterferon alfa-2a plus ribavirin for chronic hepatitis C virus infection. N Engl J Med 2002 347 : 975 82.
    • (2002) N Engl J Med , vol.347 , pp. 975-82
    • Fried, M.W.1    Shiffman, M.L.2    Reddy, K.R.3
  • 4
    • 1542378867 scopus 로고    scopus 로고
    • Peginterferon-α2a and ribavirin combination therapy in chronic hepatitis C: A randomized study of treatment duration and ribavirin dose
    • Hadziyannis SJ Sette H Morgan TR, et al. Peginterferon-α2a and ribavirin combination therapy in chronic hepatitis C: A randomized study of treatment duration and ribavirin dose. Ann Intern Med 2004 140 : 346 55.
    • (2004) Ann Intern Med , vol.140 , pp. 346-55
    • Hadziyannis, S.J.1    Sette, H.2    Morgan, T.R.3
  • 5
    • 10644264391 scopus 로고    scopus 로고
    • Treatment with pegylated interferon and ribavirin in HCV infection with genotype 2 or 3 for 14 weeks: A pilot study
    • Dalgard O Bjoro K Hellum KB, et al. Treatment with pegylated interferon and ribavirin in HCV infection with genotype 2 or 3 for 14 weeks: A pilot study. Hepatology 2004 40 : 1260 5.
    • (2004) Hepatology , vol.40 , pp. 1260-5
    • Dalgard, O.1    Bjoro, K.2    Hellum, K.B.3
  • 6
    • 20544443172 scopus 로고    scopus 로고
    • Peginterferon alfa-2b and ribavirin for 12 vs. 24 weeks in HV genotype 2 or 3
    • Mangia A Santoro R Minerva N, et al. Peginterferon alfa-2b and ribavirin for 12 vs. 24 weeks in HV genotype 2 or 3. N Engl J Med 2005 352 : 2609 17.
    • (2005) N Engl J Med , vol.352 , pp. 2609-17
    • Mangia, A.1    Santoro, R.2    Minerva, N.3
  • 7
    • 4344578833 scopus 로고    scopus 로고
    • Peginterferonalfa-2b plus ribavirin for naïve patients with genotype 1 chronic hepatitis C: A randomized controlled trial
    • Bruno S Camma C Di Marco V, et al. Peginterferonalfa-2b plus ribavirin for naïve patients with genotype 1 chronic hepatitis C: A randomized controlled trial. J Hepatol 2004 41 : 474 81.
    • (2004) J Hepatol , vol.41 , pp. 474-81
    • Bruno, S.1    Camma, C.2    Di Marco, V.3
  • 8
    • 12844279849 scopus 로고    scopus 로고
    • High-dose ribavirin in combination with standard dose peginterferon for treatment of patients with chronic hepatitis C
    • Lindahl K Stahle L Bruchfeld A, et al. High-dose ribavirin in combination with standard dose peginterferon for treatment of patients with chronic hepatitis C. Hepatology 2005 41 : 275 9.
    • (2005) Hepatology , vol.41 , pp. 275-9
    • Lindahl, K.1    Stahle, L.2    Bruchfeld, A.3
  • 9
    • 23244457832 scopus 로고    scopus 로고
    • Peginterferon-α-2a (40 KD) and ribavirin for 16 or 24 weeks in patients with genotype 2 or 3 chronic hepatitis C
    • Von Wagner M Huber M Berg T, et al. Peginterferon-α-2a (40 KD) and ribavirin for 16 or 24 weeks in patients with genotype 2 or 3 chronic hepatitis C. Gastroenterology 2005 129 : 522 7.
    • (2005) Gastroenterology , vol.129 , pp. 522-7
    • Von Wagner, M.1    Huber, M.2    Berg, T.3
  • 10
    • 17844403232 scopus 로고    scopus 로고
    • A randomized, double-blind trial comparing pegylated interferon alfa-2b to interferon alfa-2b as initial treatment for chronic hepatitis C
    • Lindsay KL Trepo C Heintges T, et al. A randomized, double-blind trial comparing pegylated interferon alfa-2b to interferon alfa-2b as initial treatment for chronic hepatitis C. Hepatology 2001 34 : 395 403.
    • (2001) Hepatology , vol.34 , pp. 395-403
    • Lindsay, K.L.1    Trepo, C.2    Heintges, T.3
  • 11
    • 21844476214 scopus 로고    scopus 로고
    • Peginterferon alfa-2b and ribavirin for treatment-refractory chronic hepatitis C
    • Krawitt EL Ashikaga T Gordon SC, et al. Peginterferon alfa-2b and ribavirin for treatment-refractory chronic hepatitis C. J Hepatol 2005 43 : 243 9.
    • (2005) J Hepatol , vol.43 , pp. 243-9
    • Krawitt, E.L.1    Ashikaga, T.2    Gordon, S.C.3
  • 12
    • 0028234491 scopus 로고
    • Intraobserver and interobserver variation in liver biopsy interpretation in patients with chronic hepatitis C
    • The French METAVIR Cooperative Study Group.
    • The French METAVIR Cooperative Study Group. Intraobserver and interobserver variation in liver biopsy interpretation in patients with chronic hepatitis C. Hepatology 1994 20 : 15 20.
    • (1994) Hepatology , vol.20 , pp. 15-20
  • 13
    • 33744803917 scopus 로고
    • SAS procedure guide for personal computers, ver. 6. CaryNC: SAS Institute Inc.
    • SAS procedure guide for personal computers, ver. 6. Cary NC : SAS Institute Inc., 1985.
    • (1985)
  • 14
    • 0003565214 scopus 로고
    • WJ Dixon. University of California Press, Berkely, CA
    • BMDP statistical software manual, vol 2, WJ Dixon University of California Press, Berkely, CA 1988.
    • (1988) BMDP Statistical Software Manual , vol.2
  • 15
    • 10644276053 scopus 로고    scopus 로고
    • Tinkering and tailoring with HCV therapy: Can we get away with less?
    • Zekry A Patel K Muir A, et al. Tinkering and tailoring with HCV therapy: Can we get away with less? Hepatology 2004 40 : 1249 51.
    • (2004) Hepatology , vol.40 , pp. 1249-51
    • Zekry, A.1    Patel, K.2    Muir, A.3
  • 16
    • 12844272774 scopus 로고    scopus 로고
    • Pushing the treatment envelope for chronic hepatitis C - Is more necessarily better?
    • Lutchman G Ghany M. Pushing the treatment envelope for chronic hepatitis C - is more necessarily better? Hepatology 2005 41 : 234 6.
    • (2005) Hepatology , vol.41 , pp. 234-6
    • Lutchman, G.1    Ghany, M.2
  • 17
    • 11144330097 scopus 로고    scopus 로고
    • Modelling how ribavirin improves interferon response rates in hepatitis C virus infection
    • All authors meet the criteria for authorship and have participated in writing this manuscript. The authors who have taken part in the research of this paper have relationships with the manufacturer of interferon alfa-2b. All have received grant support. Drs. Grace, Gordon, Krawitt, Moskowitz and Palmer and Ms. Ray have served as paid speakers for Schering-Plough. Drs. Krawitt and Palmer have served as consultants for Schering-Plough.
    • Dixit NM Layden-Almer JE Layden TJ, et al. Modelling how ribavirin improves interferon response rates in hepatitis C virus infection. Nature 2004 432 : 922 4.
    • (2004) Nature , vol.432 , pp. 922-4
    • Dixit, N.M.1    Layden-Almer, J.E.2    Layden, T.J.3

* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.